Ticker

MOLN

Molecular Partners AG

11 catalysts on file

MOLN

Molecular Partners AG

Phase 1 AI-extracted

MP0317

advanced cancer types

918d ago Jan 1, 2024

SEC 6-K verified 12h ago

Countdown card →

MOLN

Molecular Partners AG

Phase 1 AI-extracted

MP0712

small cell lung cancer

187d ago ~ Jan 1, 2026

SEC 6-K verified 12h ago

Countdown card →

MOLN

Molecular Partners AG

PDUFA AI-extracted

MP0712

small cell lung cancer

102d ago Mar 27, 2026

SEC 6-K verified 12h ago

Countdown card →

MOLN

Molecular Partners AG

Phase 2 AI-extracted

MP0317

advanced cancer types

7d ago ~ Jun 30, 2026

SEC 6-K verified 12h ago

Countdown card →

MOLN

Molecular Partners AG

Phase 2 AI-extracted

MP0712

small cell lung cancer

7d ago Jun 30, 2026

SEC 6-K verified 12h ago

Countdown card →

MOLN

Molecular Partners AG

Phase 1 AI-extracted

MP0726

ovarian cancer

7d ago ~ Jun 30, 2026

SEC 6-K verified 12h ago

Countdown card →

MOLN

Molecular Partners AG

Phase 2 AI-extracted

MP0533

relapsed/refractory acute myeloid leukemia

7d ago ~ Jun 30, 2026

SEC 6-K verified 12h ago

Countdown card →

MOLN

Molecular Partners AG

Phase 3 AI-extracted

MP0712

small cell lung cancer

T-minus 542 days ~ Dec 31, 2027

SEC 6-K verified 12h ago

Countdown card →

MOLN

Molecular Partners AG

Phase 1 AI-extracted

MP0533

acute myeloid leukemia

Date TBD Date TBD

SEC 6-K verified 12h ago

Countdown card →

MOLN

Molecular Partners AG

AdCom AI-extracted

MP0533

acute myeloid leukemia

Date TBD Date TBD

SEC 6-K verified 12h ago

Countdown card →

MOLN

Molecular Partners AG

Phase 2 AI-extracted

MP0632

solid cancers expressing MSLN and EpCAM

Date TBD Date TBD

SEC 6-K verified 12h ago

Countdown card →